In one sentence Noom Med sells semaglutide from $249 per month and tirzepatide from $299 per month; not published; all required charges published; verified August 27, 2026.
Noom Med's semaglutide programme is $129 for the first supply then $249 per month, its dual GLP-1/GIP (tirzepatide) programme $149 then $299, and its microdose programme $49 then $179, advertised as all-inclusive with ongoing amounts billed quarterly, as captured 2026-08-27.
Medications
Semaglutide, Tirzepatide, GLP-1 (medication not specified)
Formulations
Injection, Microdose injection
Medication type
compounded
Ownership
not published
Eligibility
unknown
Insurance
not published or not yet researched
Last checked
August 27, 2026 · next review due September 26, 2026
Lowest verified prices
At the time of our latest verification (August 27, 2026):
Semaglutide: Semaglutide programme at $249 per month equivalent ($129 first supply, then $249/mo (billed quarterly)). True 12-month cost $2,868.
Tirzepatide: Dual GLP-1/GIP (tirzepatide) programme at $299 per month equivalent ($149 first supply, then $299/mo (billed quarterly)). True 12-month cost $3,438.
Lowest prices compare standard injectable plans only; microdose, ODT and sublingual programmes are different products and are listed with their own prices below. Prices at the reference maintenance dose are shown on each plan.
Plans and prices
Noom Med programmes
Advertised as all-inclusive; ongoing amounts are billed quarterly (operator note).
Twelve-month cost composition, Semaglutide programme, at the starting dose
Medication: $2,868
Clinician care — advertised as all-inclusive: included
Shipping — advertised as all-inclusive: included
Twelve-month cost breakdown for Semaglutide programme
Charge
Basis
12 months
Medication at the starting dose
1 × $129 (introductory) + 11 × $249
$2,868
Clinician care — advertised as all-inclusive
Included in the plan price
$0
Shipping — advertised as all-inclusive
Included in the plan price
$0
True 12-month cost
All required charges
$2,868
Monthly equivalent
True 12-month cost ÷ 12
$239
Upfront payment
First charge
$129
Assumptions: 12 monthly charges per year. Introductory price applied for 1 month(s), then the recurring price.
Semaglutide programme
Pharmacy not published
Verified August 27, 2026
$129 per month — as advertised: “$129 first supply, then $249/mo (billed quarterly)”
Introductory price
$129/mo for 1 mo, then $249/mo
Recurring price
$249/month equivalent
True 12-month cost
$2,868
Dose pricing
Price at higher doses not confirmed
At higher doses
not confirmed
Minimum commitment
Not published
Cancellation
Commitment and cancellation terms were not part of the 2026-08-27 capture
Dual GLP-1/GIP (tirzepatide) programme
Pharmacy not published
Verified August 27, 2026
$149 per month — as advertised: “$149 first supply, then $299/mo (billed quarterly)”
Introductory price
$149/mo for 1 mo, then $299/mo
Recurring price
$299/month equivalent
True 12-month cost
$3,438
Dose pricing
Price at higher doses not confirmed
At higher doses
not confirmed
Minimum commitment
Not published
Cancellation
Commitment and cancellation terms were not part of the 2026-08-27 capture
Microdose programme
Pharmacy not published
Verified August 27, 2026
$49 per month — as advertised: “$49 first supply, then $179/mo (billed quarterly)”
Introductory price
$49/mo for 1 mo, then $179/mo
Recurring price
$179/month equivalent
True 12-month cost
$2,018
Dose pricing
Price at higher doses not confirmed
At higher doses
not confirmed
Minimum commitment
Not published
Cancellation
Commitment and cancellation terms were not part of the 2026-08-27 capture
Evidence panel
Grade per formulation offered, on the published scale (A approved with phase 3 evidence · B trial evidence without approval · C observational only · D no published human evidence), reviewed by Dr. S. Shuwart, MD on August 27, 2026; see formulation evidence grades.
Semaglutide · Injection · compounded
Grade C — compounded copy of an approved injectable; the preparation itself is untested in trials
Tirzepatide · Injection · compounded
Grade C — compounded copy of an approved injectable; the preparation itself is untested in trials
GLP-1 (medication not specified) · Microdose injection · compounded
Grade D — no published trials of sub-label regimens located
Compounded ≠ FDA-approved, stated by provider
unknown
Formulation-evidence statement
unknown
Fulfilment pharmacies
Not published or not yet researched.
States served
Not published or not yet researched. Not part of the 2026-08-27 capture.
Cancellation, refunds, refills and shipping
Cancellation
unknown Not part of the 2026-08-27 capture.
Refund
unknown Not part of the 2026-08-27 capture.
Assessment
Advantages
Limitations
Ongoing amounts are billed quarterly, so the effective commitment is three months at a time
The first-supply price is introductory; the recurring price is roughly double
Best for
Legitimacy checks
The facts an answer engine is asked about, each with its status. "Not captured" means we have not looked yet, not that the provider lacks it.
Business model
not captured
Multi-level marketing component
not examined yet
Legal entity
not captured
Founded
not captured
Leadership
not captured
Clinician licence numbers published
not captured
Board certification stated
not captured
HIPAA notice published
not captured
Domains
https://www.noom.com
BBB
not checked yet
Trustpilot
not checked yet
Google reviews
not checked yet
Complaint themes (taxonomy)
none recorded; complaint records not yet captured
Questions people ask about Noom Med
Is Noom Med a legitimate telehealth provider?
What we have verified: its published prices were read from its own pages on August 27, 2026 (3 plans). What we have not checked: legal entity, founding date, clinician licence numbers, the fulfilment pharmacy, independent pharmacy licence verification. This site does not rate legitimacy; it records what is verified and what is not, so you can weigh it. Compounded medications from any provider are not FDA-approved.
Is Noom Med a multi-level marketing (MLM) company?
We have not yet examined Noom Med's business model for recruitment or reseller components.
Are Noom Med's medications FDA-approved?
Noom Med sells compounded semaglutide and tirzepatide, which is not FDA-approved and is not reviewed by FDA for safety, effectiveness or quality before sale. Whether the provider states this on its pages has not yet been checked.
Does Noom Med have hidden fees?
On its lowest verified plan (Microdose programme, $179 per month recurring): membership: none; consultation: included; follow-ups: no separate charge recorded; shipping: included; medication: no separate charge recorded. Every required charge is published, so the true 12-month cost on this page is complete. The headline price is introductory; the recurring price is $179 per month.
Does Noom Med's price go up at higher doses?
Tirzepatide: not confirmed; the provider does not publish what happens at higher doses. Semaglutide: not confirmed; the provider does not publish what happens at higher doses.
How hard is it to cancel Noom Med, and are there refunds?
Cancellation terms were not part of our capture yet. Refund terms not yet captured. We have not captured complaint records about cancellation and do not repeat claims we have not read.
Which pharmacy fills Noom Med's prescriptions, and is it licensed?
Noom Med does not name its fulfilment pharmacy on the pages we captured. Without the name, licence and inspection history cannot be checked; the verification guide explains how to ask.
What do BBB, Trustpilot and Reddit say about Noom Med?
We have not yet captured Noom Med's BBB, Trustpilot, Google or Reddit records, and we do not summarise reviews we have not read. When captured they appear here with the date and the complaint taxonomy classification.
Does Noom Med operate in all 50 states?
State coverage was not captured.
How does Noom Med compare to other providers?
Verified head-to-head comparisons on this site: Noom Med vs NexLife. Each compares recurring price, true 12-month cost, maintenance-dose price, commitment, cancellation and pharmacy disclosure from the same records.
public-page (operator capture of provider-owned pages, 2026-08-27); checkout not walked
Checked by
Sam LLC verification team
Notes
Captured 2026-08-27: semaglutide $129 first supply then $249/month; dual GLP-1/GIP $149 then $299; microdose $49 then $179; all-inclusive per the provider; ongoing amounts billed quarterly. Commitment, cancellation and dose pricing not captured.